Clinical Trials Logo

IBS clinical trials

View clinical trials related to IBS.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT05737277 Not yet recruiting - Pediatric Clinical Trials

Gabapral in Pediatric IBS

Start date: March 1, 2023
Phase: N/A
Study type: Interventional

Irritable bowel syndrome (IBS) is a functional gastrointestinal (GI) disorder (FGID) characterized by recurrent episodes of defecation related abdominal pain associated with abnormal bowel habit. Several studies have reported significant alterations in the gut microbiota that may promote the development and persistence of IBS. Some Bifidobacterium species, mainly Bifidobacterium adolescentis, have a documented immunomodulatory effect and can modulate visceral hypersensitivity or improve the integrity of the intestinal epithelium barrier thorough its well-known ability to produce g-aminobutyric acid Thus, designed a randomised, double-blind, placebo-controlled, parallel-arm study evaluating the efficacy and safety of Bifidobacterium adolescentis PRL2019 on abdominal pain symptoms in pediatric patients with Irritative bowel sindorom